Results 211 to 220 of about 48,438 (295)

AI‐Enabled Mucus Segmentation in Nasal Endoscopy with State Space and Attention‐Based Modeling

open access: yesLaryngoscope Investigative Otolaryngology, Volume 11, Issue 3, June 2026.
We developed SUM‐MucusNet, an artificial intelligence system for reliable mucus segmentation in nasal endoscopy, designed to overcome challenges from poor image quality and illumination artifacts. The model represents a modest but statistically supported improvement over the next‐best model, achieving a Dice score of 71%. SUM‐MucusNet enables real‐time
Dipesh Gyawali   +8 more
wiley   +1 more source

Olfactory Outcomes After Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyposis

open access: yesLaryngoscope Investigative Otolaryngology, Volume 11, Issue 3, June 2026.
ABSTRACT Objective To evaluate subjective and objective olfactory outcomes in patients undergoing endoscopic sinus surgery (ESS) for chronic rhinosinusitis with nasal polyps (CRSwNP). Methods Prospective, single‐center study including adult patients undergoing ESS for CRSwNP from July 2022 to May 2024.
Elysia Grose   +4 more
wiley   +1 more source

Psychometric Validation of the Overall Symptom Severity Score for Chronic Rhinosinusitis

open access: yesOtolaryngology–Head and Neck Surgery, Volume 174, Issue 6, Page 1450-1456, June 2026.
Abstract Objective Overall symptom severity (OSS) is a global metric of chronic rhinosinusitis (CRS) symptom severity. We sought to establish psychometric validity for the OSS, which has not been previously demonstrated in the literature. Study Design Prospective, observational. Setting Academic medical center. Methods Adult patients with CRS (N = 647)
Christine W. Lee   +5 more
wiley   +1 more source

Age‐Dependent Differences in Canakinumab Safety: A Comprehensive Pharmacovigilance Analysis Using the FAERS Database

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT While the efficacy of canakinumab, an anti‐interleukin‐1β monoclonal antibody, is well‐established, its safety profile, particularly across different age groups, remains inadequately explored. Using the FDA Adverse Event Reporting System (FAERS) database, this study evaluated postmarketing safety by analyzing adverse event (AE) reports from ...
Youyang Wang   +3 more
wiley   +1 more source

The Role of MUC1 in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): The Correlation with Disease Severity. [PDF]

open access: yesJ Pers Med
Giancaspro R   +7 more
europepmc   +1 more source

Deep Learning for Endoscopic Classification of Adenoid Hypertrophy

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, Volume 12, Issue 3, Page 338-345, June 2026.
ABSTRACT Objective Endoscopy is a convenient and widely used method to evaluate adenoid size, but the subjectivity of its image diagnosis can result in over‐ or underestimation. To create a new assessment strategy for adenoid hypertrophy, we developed a reliable method for automated classification using a deep learning algorithm with nasal endoscopic ...
Xuan‐Sheng Wang   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy